好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Living with Sjögren’s: Occurrence and Impact of Neurological Manifestations
Autoimmune Neurology
P2 - Poster Session 02 (3:00 PM-4:00 PM)
1-061
To examine the occurrence of neurological manifestations and impact on quality of life (QoL) among U.S.-based adults with Sjögren’s disease (SjD).
SjD is a serious and systemic autoimmune disease affecting the entire body, including the nervous system. 
An online survey was administered August-September 2025 to U.S.-based SjD patients aged ≥18 years. The survey was IRB-reviewed and determined exempt under 45 CFR § 46.104(d)(2).

Of all respondents (N=6,360), 71% reported having been diagnosed with ≥1 nervous system related condition. The most common was neuropathy (46%), followed by migraine (38%); 59% percent of men (n=239) reported a diagnosis of neuropathy.   

A majority reported experiencing the following symptoms at least once during the 12 months prior; brain fog (77%), neuropathy (61%), feeling faint or dizzy (56%), headache (56%), and muscle weakness (54%). A majority reported daily or weekly occurrence of these symptoms (range: 64-85%) and a major or moderate impact of the symptom on their life (range: 54%-78%). A larger proportion of men reported a major or moderate impact due to symptoms of neuropathy (71% versus 63% of women), whereas 78% of women reported a major or moderate impact of brain fog, compared to 69% of men.  

Most of the sample reported at least one neurological condition or symptom (n=6072); these respondents were more likely to report SjD negatively affected their participation in social activities, in hobbies or extracurricular activities, activities of daily living, job/career or ability to work, and ability to exercise (OR range: 4.77-8.00) compared to respondents who did not report any neurological condition or symptom (n=288). Respondents with neurological manifestations were more likely to state that SjD adds an emotional burden to their life (OR 3.78).
Neurological manifestations frequently occur in SjD patients and have a major impact on QoL when compared to patients not reporting neurological conditions or symptoms. 
Authors/Disclosures
Matt Makara (Sjögren's Foundation)
PRESENTER
Matt Makara has received personal compensation for serving as an employee of Sjogren's Foundation.
Lane Destro, PhD Dr. Destro has nothing to disclose.